Investing.com -- Shares of Theratechnologies Inc (NASDAQ: THTX ) surged 44.4% following a public disclosure by Future Pak, LLC of a proposal to acquire all outstanding shares of the biopharmaceutical company. The offer, detailed in a statement today, presents a cash consideration ranging between $3.51 to $4.50 per share, which could value the company at up to $255 million.

The proposal includes $205 million in cash at closing, along with the potential for up to $50 million in additional payments tied to the performance of Theratechnologies' EGRIFTA® franchise. Specifically, the contingent value right (CVR) payments would be calculated as 50% of the annual EGRIFTA® franchise gross profit above $30 million for three years after the closing, with a one-time milestone payment of $10 million if cumulative gross profit tops $125 million within the same period.

This acquisition proposal represents a significant premium, between 164% to 238%, over Theratechnologies' closing stock price of $1.33 on April 10, 2025. Future Pak's Chief Growth Officer, Nirav Patel, emphasized the company's commitment to delivering value to Theratechnologies' shareholders and expressed hope for a constructive dialogue moving forward. Despite the premium offers made since January, Future Pak has noted only minimal engagement from Theratechnologies.

Future Pak has confirmed that the transaction would not require additional financing and is backed by Colbeck Capital Management. The company has already retained Bourne Partners Securities LLC and Honigman LLP as financial and legal advisors, respectively. Future Pak believes that, given access to necessary due diligence materials, a definitive agreement could be announced within four to six weeks.

The public disclosure of the acquisition interest by Future Pak appears to be a strategic move to prompt Theratechnologies' shareholders to consider the proposal and to compel the Board to act in pursuit of the highest value outcome for its shareholders. The market's reaction to the news indicates investor optimism regarding the potential acquisition.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.